entertainment -WSS

entertainment

author：fashion 2025-10-02 00:41:43 - browse：73531

Lung cancer under microscope — coverage from STAT — Lung cancer Adobe

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the design of a key clinical trial.

Delfi also announced that the Merck Global Health Innovation Fund, the VC arm of the drug giant, has made an investment of an undisclosed amount in the company.

Unlike Grail, a unit of Illumina, or Exact Sciences, which seeks to develop a blood test that can be used to screen for multiple types of cancer, Delfi is focusing on a single disease — lung cancer — in which the utility of screening with existing technology is not in dispute. Using low-dose CT scans to detect lung cancer is considered an established technology for people at higher risk of lung cancer. However, far too few people get screened.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Yancopoulos of Regeneron works to expand Dupixent success

Wikipedia

WSS

Pharmacists can make shortage drugs, but at what cost?

Adam's Take: Intra

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Erich Jarvis studies song birds to learn about human stuttering

STAT Summit: Michael J. Fox on progress in Parkinson's research

CRISPR technology availability, affordability needs to be expanded

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Testing GLP

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Heart attack and stroke risk calculators need revising

CEOs share strategies for surviving biotech slump

Anesthesiologist group: stop taking Ozempic before surgery

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Tori Bowie and the unacceptable rates of Black maternal death

FDA warns J&J's Abiomed: We will regulate your software

focus

STAT Summit: Biotech founders on deal

Medical devices makers are asking for forgiveness, not permission

STAT Readout Newsletter: Today's biggest biotech updates

Pharmacists can make shortage drugs, but at what cost?

Cancer, immunology, HIV research ensnared in fetal tissue politics

FDA gives detailed accounting of AI

focus

hotspot

Wikipedia

explore